TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
0.336
+0.008 (2.50%)
At close: Nov 20, 2024, 4:00 PM
0.329
-0.008 (-2.23%)
After-hours: Nov 20, 2024, 4:30 PM EST
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $5.80 million as of November 21, 2024. Its market cap has decreased by -18.55% in one year.
Market Cap
5.80M
Enterprise Value
4.08M
1-Year Change
-18.55%
Ranking
Category
Stock Price
$0.34
Market Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $5.80M, a decrease of -87.87%. That is a compound annual growth rate of -46.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 5.66M | 36.92% |
| Dec 29, 2023 | 4.14M | -52.64% |
| Dec 30, 2022 | 8.73M | -73.32% |
| Dec 31, 2021 | 32.73M | -31.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cutera | 6.04M |
| Intelligent Bio Solutions | 5.95M |
| NLS Pharmaceutics AG | 5.83M |
| Biora Therapeutics | 5.79M |
| SunLink Health Systems | 5.77M |
| Mangoceuticals | 5.59M |
| Biomerica | 5.55M |
| Aethlon Medical | 5.54M |